LabArchives is a best-in-class solution at the intersection of the ELN, LIMS, and Lab Informatics technology already used by more than 600,000 researchers in leading research organizations Enables scientists to easily document data, prove and protect discovery, and collaborate in a secure environment Further solidifies Insightful Science’s leadership position in both corporate and academic markets […]

CALGARY, AB – Nanalysis Scientific Corp. (‘the Company”, TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) is pleased to announce that it has entered into a binding agreement to acquire 100% of K'(Prime) Technologies Inc. (KPrime), a North American sales and service company, with a particular focus on scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems […]

— Acquisition will allow Codex DNA to expand its commercial BioXp™ system and biofoundry service offerings, reduce raw material costs, and accelerate overall growth strategy — SAN DIEGO — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, announced today that it has agreed to acquire Eton Bioscience, a privately held […]

Acquisition expands Quantum-Si’s capabilities in semiconductor chip assembly and packaging GUILFORD, Conn. — Quantum-Si Incorporated (NASDAQ: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences tools company commercializing a unique single molecule protein sequencing platform, today announced that it acquired Majelac Technologies LLC, a privately-owned company providing semiconductor packaging and integrated circuit assembly services. The acquisition […]

CAMBRIDGE, ON – ATS Automation Tooling Systems Inc. (TSX: ATA) (“ATS” or the “Company”), an industry-leading automation solutions provider, today announced it has entered into a definitive agreement to acquire SP Industries, Inc. (“SP”), a designer and manufacturer of high-grade biopharma processing equipment, life sciences equipment, and lab apparatus products for US$445 million (~C$550 million), subject to customary […]

FREMONT, Calif. — Cytek® Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has acquired the cell analysis business of Tonbo Biosciences™, which includes an extensive portfolio of life science research reagents related to cell preparation, flow cytometry, molecular immunology/PCR and cell culture covering application areas across immunology, apoptosis, and immunoprofiling. The […]

ArchiMed and Cube management will expand sales in the US – the world’s largest drug discovery market – and broaden Cube’s product and service offering organically and via acquisitions. Trans-Atlantic private equity healthcare specialist ArchiMed has purchased a majority stake in Monheim, Germany-based Cube. Founded in 2012, Cube has developed proprietary methods and products to […]

– Enabling solutions for biopharmaceutical development and production – Tokyo, Japan – Yokogawa Electric Corporation (TOKYO: 6841) announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess software and services. Fostering the development of the bioeconomy is one of the priority issues within Yokogawa’s sustainability goals, […]

LOS ANGELES — Calibre Scientific is pleased to announce the acquisition of Elkay Laboratory Products, a distributor of critical laboratory consumables, instruments, and services with headquarters in Basingstoke, United Kingdom. The acquisition of Elkay Labs further enhances Calibre Scientific’s growing presence in the United Kingdom. Elkay Labs is a premier distributor of products including liquid […]

KKR to support Biosynth Carbosynth with organic and inorganic growth across geographies, best-in-class products and R&D innovation London and Staad – KKR, a leading global investment firm, and Biosynth Carbosynth, a leading life sciences reagents and custom synthesis and manufacturing services company, announce today that KKR has agreed to acquire Biosynth Carbosynth from Armira and CEO […]